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Research Article
New electrophoretic and chromatographic
techniques for analysis of heparin and
heparan sulfate
Heparin (HE) and heparan sulfated glycosaminoglycans are well-known mediators of tissue
development, maintenance and functions; the activities of these polysaccharides are
depending mainly on their sulfate substitutions. The HE structure is also a very important
feature in antithrombotic drug development, since the antithrombin binding site is com-
posed by sequences of a specific sulfation pattern. The analysis of disaccharide composition
is then a fundamental point of all the studies regarding HE/heparan sulfate glycosami-
noglycan (and thereby proteoglycan) functions. The present work describes two analytical
methods to quantify the disaccharides constituting HE and heparan sulfate chains. The use
of PAGE of fluorophore-labeled saccharides and HPLC coupled with a fluorescence detector
allowed in one run the identification of 90–95% of HE disaccharides and 74–100% of rat
kidney purified heparan sulfate. Moreover, the protocol here reported avoid the N-sulfation
disaccharides degradation, which may affect N-sulfated/N-acetylated disaccharides ratio
evaluation. These methods could be also very important in clinical treatments since they are
useful for monitoring the availability kinetics of antithrombotic drugs, such as low-
molecular-weight HEs.
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1 Introduction
Heparin (HE) and heparan sulfate (HS) are sulfated glyco-
saminoglycans (GAGs) covalently bound to proteins in the
proteoglycan (PG) molecules. HE/HS proteoglycans are
widely expressed in tissues and display a variety of biological
activities, recently reviewed by several authors [1, 2]. Bio-
chemically, the HSPGs can be divided into two classes: the
first being associated to the membrane and the second one
present in extracellular matrix (ECM). As far as the PGs on
cell membrane, the most abundant are the membrane-
linked glypicans or the transmembrane syndecans [2], while
minor forms include betaglycan [3] and the V-3 isoform of
CD44 [4]. The secreted HSPGs commonly found in ECM are
perlecan, agrin [5] and collagen XVIII [1], the last one espe-
cially associated with the basement membrane.
All GAGs are linear polysaccharide chains, and every
GAG is defined by the repetition of specific disaccharide
units, one hexosamine and one uronic acid (UA) or neutral
hexose, with proper glycosidic bonds. The characteristic di-
saccharide composing HE and HS is UA-glucosamine. The
UA is either iduronic or glucuronic (GlcA) acid and the glu-
cosamine (GlcNH2) substituted with N-acetyl or N-sulfonyl
groups (GlcNAc or GlcNS): [-b(1,4)-UA-b(1,4)-GlcNb1-]n.
The biosynthesis of the HE/HS chain is a complex sequence
of events inside the Golgi apparatus, in which a high number
of enzymes takes part. Glycosyltransferases, sulfo-
transferases and epimerases are the major enzyme classes
committed in this process that can be divided into the fol-
lowing steps: chain initiation with the bound of the linkage
tetrasaccharide to the core protein (process shared with
chondroitin/dermatan sulfate (CS/DS) proteoglycans); chain
elongation by the stepwise addition of GlcA and GlcNAc
residues carried out by glycosyltransferases; chain modifica-
tion including epimerization of glucuronic to iduronic acid,
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N-deacetylation/N-sulphation of GlcNAc residues into
GlcNS or GlcNH2, 2-O-sulphation of the UA, 6 and/or 3-O-
sulphation of the hexosamine [6]. Because of the restric-
tions of the biosynthetic pathway due to the specific target
of the involved enzymes, only few among the potential
HE/HS disaccharides have been effectively identified in
biological samples [6]. The analysis of the composition of
the HE/HS chain is usually performed on unsaturated
disaccharides (D-disaccharides) obtained after complete
digestion of the GAG with HE lyases (I, II, III) in combi-
nation. After this treatment several studies reported the
presence of only 12 D-disaccharides (see [7] for a compar-
ison of literature data), which are present selectively in HE
or heparan sulfate.
The importance of the knowledge of the GAG composi-
tion is actually due to the role of HE/HS in biological activi-
ties: these polysaccharides are involved in critical passages of
cellular and tissue biology, both in physiological and patho-
logical condition, but all their behaviors are dependent on
their chemical structure, composition and sequence [2, 6].
After the determination of the antithrombin binding site of
HE [8] the relationships between protein (such as growth
factors) and polysaccharides (such as HE) were deeply
investigated and since then a new concept of specificity was
considered. In fact, it is noteworthy that in many cases and
unexpectedly the overall organization of the GAG can be
more important than the fine structure for the protein/GAG
interaction [9]. Recently the studies about the comprehen-
sion of GAG composition have increased as with the knowl-
edge of the role of these polysaccharides in development and
cellular progression [10, 11]. Nevertheless, the structural
analyses are not yet easy to perform, principally due to the
absence of suitable tools. In fact the derivatization procedure
by Calabro [12] was carried out for chondroitin sulfate and
hyaluronan (HA) and the reported conditions were not suit-
able for HE/HS, due to the degradation of the N-sulfated
disaccharides [13]. The aim of this work is to simplify the
analysis of HE/HS composition using easy and convenient
HPLC or electrophoretic methods in combination with the
fluorescence labeling of the samples which improves the
assay sensitivity. The methods developed in our laboratory
and here described permit a complete separation of the
known D-disaccharides HE/HS found in tissues in few and
simple steps improving the similar techniques reported in
the literature [7, 13].
2 Materials and methods
Standards of HE/HS disaccharides A and S series were from
Seikagaku (Tokyo, Japan); standards of HE/HS disaccharides
H series were from Sigma (St. Louis, MO, USA). Proteinase
K (EC 3.4.21.64) was from Finnzymes (Espoo, Finland). Por-
cine Intestinal Mucosa Heparin was from Sigma. Hepar-
inase I (E.C. 4.2.2.7), heparinase II (no number E.C.) and
heparinase III (E.C. 4.2.2.8) are from Sigma–Aldrich (Stein-
heim, Germany). AMAC was obtained from Molecular
Probes (Eugene, OR, USA) and NaBH3CN from Sigma–
Aldrich. ACN HPLC grade was from Merck (Darmstadt,
Germany). Acrylamide, N,N0-methylenebisacrylamide,
TEMED and ammonium persulfate were obtained from
BioRad (Richmond, CA). All other chemicals used were of
analytical reagent grade.
2.1 Isolation and degradation of HS and HE GAGs
A fresh rat kidney sample was digested at 607C for 2 h in
300 mL of 100 mM ammonium acetate buffer, pH 7.0, con-
taining 20 U/mL of Proteinase K. The enzymatic treatment
was terminated by boiling for 5 min. A 4 vol. of 96% ethanol
per sample volume was added, and the GAGs in the mixture
were precipitated at 2207C overnight. Ethanol-precipitated
GAGs were centrifuged at 11 0006g at 47C for 30 min. The
obtained pellets were dried and dissolved in 100 mL of
100 mM ammonium acetate, pH 7.0, containing a mix of
heparinases I, II, III, 50 mU/mL each, and digested at 377C
for 16–18 h. A 4 vol. of 96% ethanol per sample volume was
added, and the GAGs in the mixture were precipitated at
2207C overnight, while the unsaturated disaccharides (D-
disaccharides) from HS were recovered in the supernatant
and lyophilized.
Commercial HE was dissolved at 10 mg/mL in 100 mM
ammonium acetate, pH 7.0 and treated as reported above for
HS. The D-disaccharide digested products were then deriva-
tized as described below.
2.2 Derivatization procedure
Derivatization of HE/HS standards was first done as
described by Calabro et al. [12], using 5 nmol of each
standard D-disaccharide. A 40 mL volume of 12.5 mM
AMAC solution in glacial acetic acid/DMSO (3:17 v/v) was
added, and samples were incubated for 10–15 min at room
temperature. A 40 mL volume of a freshly prepared solution
of 1.25 M NaBH3CN in water was added to each sample
followed by an overnight incubation at 377C. An appropri-
ate dilution of these samples in ammonium acetate
100 mM pH 7.0 or the addition of 20% glycerol was used
for the HPLC analysis or the PAGE of fluorophore-labeled
saccharides (PAGEFS), respectively.
Alternatively the samples were labeled with AMAC as
described by Militsopoulou et al. [7]; briefly, 10 mL of a
100 mM AMAC solution in glacial acetic acid/DMSO (3:17
v/v) and 10 mL of 100 mM NaBH3CN in water were added to
the lyophilized samples, vortexed, centrifuged at 11 0006g
for 3 min and incubated at 457C for 4 h. At the end of the
labeling 60 mL of 50% DMSO was added and for PAGEFS
analysis 20 mL of glycerol or, alternatively, 50% glycerol,
430 mM Tris-HCl, 4% NaOH [13].
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2.3 HPLC analysis
Separation and analysis of AMAC-derivatives of D-di-
saccharides were modified from Karousou et al. [10] using
an HPLC system coupled with a Jasco-Borwin chromato-
graph system with a fluorophore detector (Jasco FP-920,
lex = 425 nm and lem = 525 nm). Chromatography was
carried out using an RP column (C-18, 4.66150 mm2,
Bischoff 3.0 mm) at room temperature, equilibrated with
0.1 M ammonium acetate buffer, pH 7.0, filtered through a
0.22 mm membrane filter. A gradient elution was done
using a binary solvent system composed of 0.1 M ammo-
nium acetate buffer, pH 7.0 (eluent A), and ACN (eluent
B). The flow rate was 1 mL/min, and the following pro-
gram was used: gradient elution to 12.5% eluent B for
30 min, to 50% for 10 min, re-equilibration of the column
with 100% eluent A for 10 min. Sample peaks were iden-
tified and quantified comparing the fluorescence spectra
with standard D-disaccharides, using Jasco-Borwin soft-
ware.
2.4 PAGEFS
A MiniProtean II or III cell vertical slab gel electropho-
resis apparatus (BioRad) was used with 7.2-cm plates,
0.75 mm spacers, and wells of 0.5 cm. The stock solu-
tions were 1.5 M Tris-HCl, pH 8.8, 500 mM Tris-HCl
pH 6.8. Acrylamide solution T 50%/C 5% (% T refers to
the total concentration w/v of acrylamide monomer (i.e.
acrylamide plus methylenebisacrylamide); % C refers to
the concentration w/w of cross-linker relative to the total
monomer).
A 10 mL volume (for two gels) of T 30%/C 3%, 375 mM
Tris-HCl pH 8.8 resolving gel buffer solution (final con-
centrations) was prepared and degassed. TEMED (5 mL) and
a 50 mL of 10% w/v ammonium persulfate were added. The
solution was carefully mixed before and placed between the
glass plates; the gels had a length of at least 6 cm. The
stacking gel was prepared in a volume of 5 mL (for two gels)
of T 5%/C 0.5%, 120 mM Tris-HCl pH 6.8 gel buffer solution
(final concentrations) with added 10 mL of TEMED and 50 mL
of 10% w/v ammonium persulfate for the polymerization.
The running buffer was 25 mM Tris-HCl and 192 mM
glycine pH 8.3.
The run was performed at 180 V for 45 min and at 400 V
for 10–15 min or until disaccharides resolution. During the
run the gel was kept at 47C in the cold room.
A PAGEFS gel with D-disaccharides from commercial
HE and rat kidney HS and a curve of standard unsaturated
heparan sulfate disaccharide (DDiHS)-6S disaccharide was
run and the gel was scanned in a UV-light box using a CCD
camera (Gel Doc 2000 System). The identification and the
quantification of the bands were done using ImageJ Software
comparing migration and pixel density with standard di-
saccharides as reported by Karousou et al. [10].
3 Results and discussion
The importance of the arrangement of HE/HS chains in tis-
sue development and maintenance is well known in specific
literature. Therefore, the aim of this work is to set up a quick
and sensitive method for defining the composition profile of
the HE/HS GAG chains.
Basically, the analysis of GAG chain composition begins
with the treatment that employs appropriate lyases to produce
unsaturated disaccharides; in this case the digestion was car-
ried out using heparinases I, II, III, three enzymes with dif-
ferent substrate specificity able to completely degrade the HE/
HS chains to disaccharide units [14]. Depending on the
selected method for the analysis, the digestion may be fol-
lowed by the labelling with a fluorescent dye, for improve-
ment of measurement sensitivity. The best label for charged
molecules is 2-aminoacridone (2-AMAC) [15, 16]. After 2-
AMAC labeling, the detection of the resolved GAG D-di-
saccharides allows measurement at an extraordinary sensitive
level, with the fluorescence response linear from 10 to
75 pmol [10]. Some previous works with fluorescent HE/HS
D-disaccharides (derivatized with 2-AMAC) were performed
by Militsopoulou et al. [7] and Lauer et al. [13], using the CE
and the gel electrophoresis technologies, respectively. The
former paper describes a method to discriminate twelve D-
disaccharides composing HE and HS, using a CZE with an
LIF detector. Because of the high costs, this equipment is not
very common. The study also reports the presence of only 12
D-disaccharides in mammal samples, highlighting the lim-
ited number of disaccharides actually composing the pro-
teoglycan HE/HS chain. The latter study focuses on the anal-
ysis of HS from diabetic rat glomeruli, and uses a commercial
patented gel electrophoresis kit leading to the separation of
five or six of the most representative HE/HS disaccharides.
The analysis allows the measurement of the ratio between
N-acetylated and N-sulfated disaccharides obtained after HS
digestion. Although the second method to analyse HE/HS is
more convenient for common research laboratories, it dis-
criminates only a limited number of HE/HS disaccharides
present in mammals. Nevertheless, electrophoretic methods
are very suitable for the quick and simple comparison of
multiple samples within one gel and for a qualitative evalu-
ation of the difference in composition of GAG chains, HA
[10] and CS/DS [11], or HE/HS [13]. The differences in res-
olution were on the basis of buffers salts, acrylamide, bis-
acrylamide, TEMED concentration and pH value. The borate
buffer is suitable for the electrophoresis separation of not
sulfated D-disaccharides, i.e. the ones derived from HA and
chondroitin chains [10] while the Tris-HCl buffer is to be
preferred in the case of sulfated disaccharides, as reported in
our previous work [11]. For these reasons, the analysis of D-
disaccharides from HE/HS chains reported here is per-
formed on a Tris-HCl-buffered polyacrylamide gel with a
modified buffer composition, that is optimized for the
separation of six most representative HE/HS D-di-
saccharides as reported in Figs. 1 and 2, both in single and in
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Figure 1. (A) PAGEFSof standard
HE/HS disaccharides; 40 pmol of
2-AMAC-derivatized disaccharide
ofAandSseries; lanes:1,mixof I-
S, II-S, III-S, IV-S, II-A and IV-A; 2,
IV-A; 3, IV-S; 4, II-A; 5, I-S; 6, III-S; 7,
II-S (for sulphation pattern see
Tables 1 and 2). The arrow is
pointed to an artefact due to a
contaminant (for comments see
Section3). (B)40 pmolof2-AMAC
disaccharide IV-A in two different
conditions: with not freshly pre-
pared or new running buffer,
lanes 1 and 2, respectively.
Figure 2. PAGEFS of HE/HS disaccharides; lanes 1–6 100 pmol of
2-AMAC-derivatized disaccharide of A and S series: lanes: 1, IV-A;
2, II-A; 3, IV-S; 4, II-S; 5, III-S; 6, I-S (for sulphation pattern see
Table 1). HE: 1/100 of final derivatized volume of HE di-
saccharides; HS: 1/50 of final derivatized volume of rat kidney
heparan sulfate disaccharides.
mixed preparation. The figures show a good separation of the
most common disaccharides present in nature in HS and
HE [7], allowing their analysis by semiquantitative measure-
ments.
There are three HE/HS disaccharides series commer-
cially available (see Tables 1 and 2), they all have specific O-
sulfations (2 or 6), but they differ in hexosamine N-sub-
stitution. In fact, the H series is characterized by di-
saccharides containing a glucosamine, the S series a N-sul-
fated glucosamine and the A series a N-acetylglucosamine
(this series is incomplete, since only two disaccharides are
available). In Fig. 1, it is reported the separation of the A
and S series D-disaccharides from HE/HS after 2-AMAC
labelling. As the disaccharides of H commercial series are
scarcely purified and poorly concentrated, even the sensitive
PAGEFS technique was not able to detect fluorescent prod-
uct bands.
Therefore, the PAGEFS analysis was then carried out
only with A and S disaccharides, the most common and
representative ones, as reported in Militsopoulou et al. [7].
The bands in the gel of Fig. 1A represent 2-AMAC HE/HS
disaccharides standards; in the figure the arrow indicates a
band which is an artefact due to impurities in the dye, in
derivatization reagents (that should be freshly done imme-
diately before use) or in the running buffer. In this context
the buffer preparation plays a critical role, in fact the same
sample, IV-A (DDiHS-0S) run with a not fresh running buf-
fer caused the presence of the contaminant band, whereas in
the separation of the same sample carried out with a freshly
prepared running buffer, the contaminant disappeared
(Fig. 1B). The buffer was notice to give a contaminant in the
PAGEFS if used more than once or if let stored at 47C for
more than 1 wk. We did not further explore this aspect.
The stability of the reagent mixture is important for the
whole derivatization procedure, in fact Lauer et al. [13] report
the effect of acidic pH on the loss of N-sulfated disaccharides
during the overnight derivatization procedure, a protocol
usually used for HA and CS/DS disaccharides analysis [10,
11]. The derivatization of samples used for PAGEFS tech-
nique here described, was then modified in accordance with
Militsopoulou et al. [7], where the addition of cyanoboro-
hydride occurs immediately before the 2-AMAC solution, the
derivatization time is shortened to 4 h (see Section 2) and the
addition of glycerol is done with a buffered solution. Such
procedure is suitable for keeping the sample at 2807C in
order to maintain the amount of N-sulfated disaccharides
unchanged.
The separation of the D-disaccharides occurs on the basis
of sulphation grade, since higher sulfated D-disaccharides
run faster than the ones with lower sulphation. Likely
depending on a different geometry of the sulfate groups,
disaccharides with the same sulfate content showed different
migration (for example IV-S and II-A or II-S and III-S). The
D-disaccharides standard resolved by PAGEFS account to the
90% of total HE disaccharides, as well as the 74% of total HS
disaccharides, as reported in literature [13]. Unlike the ready
to use kit used by Lauer et al. [13] the PAGEFS technique
described in this study is always able to separate all the
available disaccharides of A and S series; moreover, the pro-
cedure allows the researcher to monitor continuously the
separation of D-disaccharides and therefore to adapt the
technique to a specific condition and sample characteriza-
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Table 1. PAGEFS versus HPLC analysis of D-disaccharides from commercial HE and rat kidney HS
D-Disaccharide Structure HS from rat kidney Commercial HE
HPLC PAGEFS HPLC PAGEFS
I-S (DDiHS-triS) a-DUA-2S-[1?4]-GlcNS-6S – – 76.7 71
II-S (DDiHS-diS1) a-DUA-[1?4]-GlcNS-6S 5.9 15 5.4 6
III-S (DDiHS-diS2) a-DUA-2S-[1?4]-GlcNS 5.8 20 – –
IV-S (DDiHS-NS) a-DUA-[1?4]-GlcNS 24.7 11 11.2 5
IV-A (DDiHS-0S) a-DUA-[1?4]-GlcNAc 55.4 54 2.6 7
II-A (DDiHS-6S) a-DUA-[1?4]-GlcNAc-6S 0.6 – 4.2 11
Table 2. HPLC analysis of D-disaccharides from commercial HE and rat kidney HS




I-H a-DUA-2S-[1?4]-GlcN-6S 24.7 16.1
II-H a-DUA-[1?4]-GlcN-6S – –
III-H a-DUA-2S-[1?4]-GlcN 28.1 6.5
IV-H a-DUA-[1?4]-GlcN – 10.2
I-S (DDiHS-triS) a-DUA-2S-[1?4]-GlcNS-6S – 51.5
II-S (DDiHS-diS1) a-DUA-[1?4]-GlcNS-6S 3.0 3.6
III-S (DDiHS-diS2) a-DUA-2S-[1?4]-GlcNS 3.0 –
IV-S (DDiHS-NS) a-DUA-[1?4]-GlcNS 12.6 7.5
IV-A (DDiHS-0S) a-DUA-[1?4]-GlcNAc 28.3 1.7
II-A (DDiHS-6S) a-DUA-[1?4]-GlcNAc-6S 0.3 2.8
tion. The application of this technique to GAG analysis is
shown in Fig. 2. The analysis was carried out on prepara-
tions of commercial HE and on HS GAGs purified from
normal rat kidney. The samples present a very different
patterns, in facts HE shows an high amount of di- or tri-
sulfated D-disaccharides, whereas in rat kidney the analy-
sis shows the presence of HS disaccharides with a minor
degree of sulfation [7]. In order to confirm PAGEFS data,
we develop a new HPLC method to evaluate the 2-AMAC
labeled HE/HS disaccharides. For this purpose we used
RP chromatography in an HPLC system equipped with a
fluorescence detector. This method was modified from a
technique already described for the analysis of HA [10]
and CS/DS GAGs [11]. The modification of the elution
gradient for highly charged D-disaccharides here reported,
is able to obtain a complete separation of HE/HS dis-
accharides. The sample preparation for HPLC and
PAGEFS analysis is the same, therefore the combination
of these procedures is able to overcome the possible pres-
ence of contaminants in PAGEFS. In Table 1, the analysis
of D-disaccharides from commercial HE and rat kidney
HS is reported in comparison with the results obtained by
PAGEFS. The two methods present some differences in
the quantification of the disaccharides that might be due
to the impossibility to identify the H series D-di-
saccharides with PAGEFS technique. In fact, the HPLC
analysis leads to the separation of all D-disaccharides
standards: A, S and H series (Fig. 3C) with high resolu-
tion and reproducibility, permitting to resolve all the 10 D-
disaccharides known in the GAG chain of HS and almost
95% of the HE disaccharides [7]. The HPLC separation of
standard disaccharides, commercial HE and rat kidney
HS is reported in Fig. 3, where the reproducibility and
sensitivity of this HPLC-based technique applied to dif-
ferent biological samples is evident. In Table 2, the HPLC
quantification of all D-disaccharides contained in com-
mercial HE and rat kidney HS is reported. As reported for
PAGEFS, HE demonstrated an elevated concentration of
highly charged disaccharides, up to 52% of trisulfated
ones, and very low amounts of mono- or disulfated ones.
Concerning unsulfated disaccharides, the presence of a
minimal amount (1.7%) of IV-A (OS-GlcNAc disaccharide)
it is noteworthy and more interestingly is an about 10%
amount of IV-H (OS-GlcNAc disaccharide). HS presents a
lower sulfate concentration and an increased variety of
sulphation pattern, with the prevalence of not- or mono-
sulfated disaccharides, a 31% of disulfated residues with-
out any trisulfated disaccharides.
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Figure 3. HPLC chromatograms of (A) mix of standard HE/HS
disaccharides 100 pmol each from A, H and S series. Peaks: 1, I-S;
2, II-S; 3, III-S; 4, IV-S; 5, I-H; 6, II-A; 7, III-H; 8, IV-H: 9, IV-A; 10, II-H
(see Tables 1 and 2); (B) 1/1000 of final derivatized volume of rat
kidney heparan sulfate disaccharides; (C) 1/1000 of final deriva-
tized volume of commercial HE disaccharides.
4 Concluding remarks
In the present work, we describe a new ultrasensitive method
for the analysis of HE/HS disaccharides. This is remarkably
important considering that recent studies about the PGs
reveal a new point of view on glycoscience: the composition
of the saccharidic moieties is not a static component of the
molecules, but GAGs are the true variable portion of the PGs
and play a pivotal role during physiological events such as
ageing [17] and in several pathologies [11, 13]. The awareness
of the adaptability of the GAG portion of the PGs and the
critical role in binding growth factors underline the need of
tools for defining the exact composition of GAGs in a sensi-
tive and easy way to perform. On the basis of our results the
PAGEFS method seems to be more suitable for fast qualita-
tive analysis, even the quantification of samples is possible
using standard curves obtained from commercial dis-
accharides, whereas HPLC approach showed a longer proce-
dure but a more powerful analytic capacity as it was able to
separate all disaccharides.
In particular, our understanding of the HE/HS impor-
tance to control biological effects on cells and tissues has
greatly improved starting from the discovery of anti-
thrombotic activity of HE [8]. Nowadays, the relationship be-
tween HS chain alteration and the onset of pathologies (see
for example [18] and [1]) is a cornerstone of glycobiology re-
search. The GAGs analysis including CZE, PAGEFS and
HPLC for qualitative and quantitative measurement of dis-
accharides from HA, CS/DS is now available also for HE/HS.
In fact, the present report shows for the first time the
separation of HE/HS fluorescent disaccharides by PAGEFS
and HPLC, improving dramatically the sensitivity of the
methods. Moreover, the PAGEFS and HPLC methods are
reproducible, rapid and useful for laboratory research, lead-
ing the quantification of most of HE and HS disaccharides,
representing a useful tool for glycobiology research. For
clinical chemistry, the HPLC methods could be a proper,
rapid and simple procedure for monitoring the amount of
low-molecular-weight HE used as antithrombotic drug in
several pathologies, and the quantitative and qualitative
analysis allowed by our method can improve dramatically the
specificity of HE determination. In fact, the amount of HE or
HE fragments in plasma of patients is a critical point for the
treatment effectiveness [19], and the detection of I-S di-
saccharides in plasma may be a powerful tool for a more
tuned therapy.
The authors are in debt to Andrea Moriondo for the rat kid-
ney specimen. The authors are grateful to “Centro di Servizi
Grandi Attrezzature per la Ricerca Biomedica dell’Università
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